Concepedia

Thomas Lochmann

TL

Statistics

Publications

3

Citations

38

H-Index

3

Active since

1997

Affiliations

Novartis (Switzerland)(Current)

Novartis (United States)

Thomas Lochmann is an author at Novartis (Switzerland) specializing in nucleic acid synthesis, pharmacy, and nucleic acid chemistry.

Publications per year

1997–2020

3

Publications

3

Replacement of the phosphodiester linkage in oligonucleotides by heterocycles: synthesis of thymidine dinucleotide analogs with triazole-modified backbones

Peter Matt, Thomas Lochmann, Karl‐Heinz Altmann · Bioorganic & Medicinal Chemistry Letters · 1997 · 16 citations

, , +15

An expeditious synthesis of 3′-α-carboxymethyl-2′-O-methyl ribonucleosides

Peter Matt, Thomas Lochmann, Rudolf Kesselring et al. · Tetrahedron Letters · 1999 · 12 citations

, , +8

Kendomycin Cytotoxicity against Bacterial, Fungal, and Mammalian Cells Is Due to Cation Chelation

Dale Tranter, Ireos Filipuzzi, Thomas Lochmann et al. · Journal of Natural Products · 2020 · 10 citations · Full text

, , +10

1–3 of 3